Webinars

Watch this webinar to discover qualified bioassays assessing therapeutic antibody mechanisms, case studies about agonistic effects in antibodies initially deemed…

Inherent donor variability of immune effector cells presents a significant challenge for developing a robust and reproducible ADCC assays for…

It is well established that ligand binding can protect proteins from thermal denaturation in a cellular milieu; however, the broad…

Protein kinases are critical to many cellular pathways and play a role in several therapeutic areas such as oncology, inflammation,…

The screening and functional characterization of novel ligands for G-Protein Coupled Receptors (GPCR) remains a key focus in drug discovery.…

This 30-minute webinar shows you how to make your own cell-based assays to analyze β-arrestin recruitment in any cell type.…

The complex interactions between tumor cells and the host immune system are only beginning to be understood, however it is…

Kinase inhibitors often potently inhibit several off-target kinases in biochemical assays. Unfortunately, the relevance of these off-target interactions in a…

Opioid receptors are among the most well-known GPCRs that regulate the transmission and perception of pain. Clinical management of severe…

Here we will describe InCELL Pulse™, which uses DiscoverX’s Enzyme Fragment Complementation (EFC) technology to overcome these limitations of current…

PBMC effector cells have inherent donor variability, reducing their consistency and reproducibility in lot release assays. Antibody-Dependent Cell Cytotoxicity (ADCC)…

GPCRs are privileged drug targets. Approximately 100 receptors still escape from the drug discovery process as they are orphans, without…